Antioxidant

In a landmark study published in ‘Drug and Chemical Toxicology,’ researchers have elucidated the influence of specific β-lactam antibiotics on antioxidant defense mechanisms and lipid peroxidation processes within different rat tissues. The research sheds light on the potential biochemical effects of widely-used pharmaceuticals such as cefazolin, cefuroxime, and cefoperazone, revealing their impact beyond their primary infection-fighting role.

DOI: 10.1080/01480545.2019.1608230

Introduction

Antioxidant enzymes constitute a critical part of the body’s defenses, protecting cells against the detrimental effects of free radicals and oxidative stress. When the generation of free radicals outweighs the body’s ability to neutralize and eliminate them, oxidative stress can result, leading to cellular damage and contributing to various diseases. Conversely, lipid peroxidation is a process whereby free radicals attack lipids containing carbon-carbon double bond(s), leading to cell membrane damage and a host of associated pathologies.

The study, co-authored by Fikret Türkan and colleagues from institutions such as Igdır University, Van Yuzuncu Yıl University, and Atatürk University, has brought to light the interaction between drug administration and oxidative stress within vital organs. The research focused on three β-lactam antibiotics: cefazolin, cefuroxime, and cefoperazone, assessing their effects on antioxidant enzyme levels and markers of lipid peroxidation in the kidney, liver, and brain tissues of albino female rats.

Methods

Ninety-six albino rats were assigned randomly into sixteen groups, with the treatment groups receiving varying dosages of the antibiotics mentioned. Antioxidant enzyme activity—namely superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx)—and the levels of malondialdehyde (MDA), a key marker of lipid peroxidation, were measured in harvested tissue samples post-treatment.

Results

The results indicated a drug-specific influence on antioxidant enzyme activity. For instance, cefazolin administration led to a notable increase in SOD and GPx activity in kidney tissues. Interestingly, a similar upsurge was not observed in the liver or brain tissues, suggesting a selective organ response to the antibiotic.

Cefuroxime exposure resulted in a marked rise in CAT activity in liver tissues, but this was not paralleled in the kidney or brain tissues. In the case of cefoperazone, there was evidence of augmented CAT activity across all examined tissues—a more systemic effect that implies a broad-spectrum influence on cellular oxidative stress mechanisms.

Central to the findings was the observation that despite fluctuations in antioxidant enzyme activity, there was a consistent increase in MDA levels in the tissues following drug administration. This increase signals an augmentation in lipid peroxidation, which could be indicative of heightened oxidative stress induced by the antibiotics.

Discussion

The research team proposed that the administration of these β-lactam drugs could trigger an adaptive response from the body’s antioxidant systems—an attempt to mitigate the potential increase in free radical production. However, the concomitant rise in MDA levels across all tissues suggests that the antioxidant defense mechanisms may be insufficient to completely counteract the oxidative stress induced by these drugs.

This research unlocks several avenues for further exploration, such as the long-term implications of antibiotic-induced oxidative stress on organ health and the possible need for adjunctive antioxidant therapy during antibiotic treatment. While the study was conducted on non-human subjects, the implications for humans, particularly in cases of extended antibiotic use, warrant considerable attention.

Conclusion

The study consolidates the hypothesis that β-lactam antibiotics, while essential for combatting bacterial infections, can inadvertently generate oxidative stress with potential ramifications for different organ systems. The observed organ-specific and drug-specific responses suggest that a one-size-fits-all approach to antioxidant management during antibiotic treatment may not be adequate.

This novel insight into the side effects of cefazolin, cefuroxime, and cefoperazone on oxidative balance in biological tissues provides a crucial consideration for clinicians prescribing these medications. As we enhance our understanding of drug-induced metabolic processes, the need to devise strategies to minimize unintended biochemical impacts becomes increasingly pressing.

Keywords

1. β-lactam antibiotics
2. Oxidative stress
3. Antioxidant enzymes
4. Lipid peroxidation
5. Cefazolin
6. Cefuroxime
7. Cefoperazone

References

1. Türkan, F., Huyut, Z., Basbugan, Y., & Gülçin, İ. (2020). Influence of some β-lactam drugs on selected antioxidant enzyme and lipid peroxidation levels in different rat tissues. Drug and Chemical Toxicology, 43(1), 27-36. DOI: 10.1080/01480545.2019.1608230

2. Sies, H. (1997). Oxidative stress: oxidants and antioxidants. Experimental physiology, 82(2), 291-295. DOI: 10.1113/expphysiol.1997.sp004024

3. Halliwell, B., & Gutteridge, J. M. (2015). Free radicals in biology and medicine. Oxford University Press, USA.

4. Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., & Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. The international journal of biochemistry & cell biology, 39(1), 44-84. DOI: 10.1016/j.biocel.2006.07.001

5. Yildirim, O. T., Yildirim, T., Seckin, I., Kutlu, M., & Simsek, B. (2011). The effects of antibiotics on oxidative stress and antioxidant enzyme systems. Advances in Bioscience and Biotechnology, 2(06), 504. DOI: 10.4236/abb.2011.26077